Tebipenem Pivoxil Hydrobromide Patent Expiration
Tebipenem Pivoxil Hydrobromide was first introduced by Glaxosmithkline Llc
Tebipenem Pivoxil Hydrobromide Patents
Given below is the list of patents protecting Tebipenem Pivoxil Hydrobromide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Utebzi | US10889587 | Tebipenem Pivoxil Crystalline Forms, Compositions Including The Same, Methods Of Manufacture, And Methods Of Use | Feb 06, 2038 | Glaxosmithkline |
| Utebzi | US12226403 | Tebipenem Pivoxil Immediate And Modified Release Oral Dosage Forms | Dec 15, 2037 | Glaxosmithkline |
Tebipenem Pivoxil Hydrobromide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List